These two disorders share symptoms such as severe headaches, risk factors like obesity and sleep problems, and elevated levels of a brain chemical called calcitonin gene-related peptide (CGRP)
Importantly, research has also shown that upon discontinuing the medication, much, if not all, of the weight is regained
After clinician review, both treatments continued without adjustment, and symptoms were monitored to ensure comfort and safety
Struggling with stubborn weight, nonstop hunger, or blood sugar swings that make every diet fail by week two
The other 80 women in the study, who were on tirzepatide alone, lost an average of 14 percent of their body weight
But patient access has been a consistent problem because of their cost around $500 a month for higher doses and insurance coverage has been spotty